Novel Start Trial

 
 
Sign in
Get in touch with us at Spiral if you would like to see more of our software spinnaker@spiral.co.nz

 

About the Novel START Study

The Novel START (Novel Symbicort Turbuhaler Asthma Reliever Therapy) study is a 52- week, open label, parallel group, multicentre, phase III, randomised controlled trial to compare the efficacy and safety of three asthma treatment regimens.

Participants will be recruited from sites in 9 regions in 4 countries (New Zealand, Australia, Italy and the United Kingdom).

About the software

Spinnaker is a tailored, web based, software and database solution for managing your multi-centre clinical study including the recording of patient data, recording and alerting of events, inventory management and reporting on data collected during the course of your study. Spinnaker is user friendly, adaptable and can be delivered quickly. You can read more on the Spinnaker website or contact Audrey on spinnaker@spiral.co.nz.

 

You can get to know us a little better through our blog and social media pages accessed via the logout screen of this trial.